Related Experiment Video
Updated: Sep 25, 2025

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
Coronavirus Disease 2019 (COVID-19) and Ecchymosis: A Case Report
Jing Hong Fong1,2, Sabrina Mei Ann Koay2, Edwin Hsiang Win Foo3
1Department of Emergency Medicine, North West Regional Hospital, Burnie, AUS.
Insights
A rare case of ecchymosis, a type of skin bruising, associated with coronavirus disease 2019 (COVID-19) is reported in Malaysia. This finding contributes to understanding COVID-19
Area of Science:
- Dermatology
- Infectious Diseases
- Pathophysiology
Background:
- Cutaneous manifestations are increasingly recognized as extrapulmonary symptoms of COVID-19.
- COVID-19 rashes are typically livedo and purpuric, with six recognized patterns.
- Understanding these skin lesions aids in diagnosing COVID-19 complications.
Observation:
- This report details the first case of ecchymosis linked to COVID-19 in Malaysia.
- The patient had no preceding history of coagulopathy.
- This highlights a rare clinical association of COVID-19.
Findings:
- Ecchymosis, a purpuric rash, is a potential cutaneous manifestation of COVID-19.
- The absence of prior coagulopathy in the patient suggests a direct link to the viral infection.
- This case expands the spectrum of known COVID-19-related skin findings.
Implications:
- This rare association may have pathophysiological significance in COVID-19.
- It contributes valuable data to the understanding of COVID-19's cutaneous manifestations.
- Further research into these lesions could improve early diagnosis and management of COVID-19 complications.
Abstract:
Extrapulmonary symptoms such as cutaneous manifestations are increasingly being reported in coronavirus disease 2019 (COVID-19) infection. The rashes of COVID-19 are usually livedo and purpuric and have been classified into six main patterns. This is the first case reported in Malaysia of ecchymosis associated with COVID-19 occurring on a patient without prior history of coagulopathy. The report of this rare clinical association could have a potential pathophysiological implication and contributes to the current data of the cutaneous manifestations of COVID-19. Further knowledge regarding these cutaneous lesions could help in the diagnosis of COVID-19 related complications and earlier management.
Related Concept Videos
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Endocarditis II: Clinical Features of Infective Endocarditis
Cardiovascular System Abnormal Findings I: Inspection and Palpation
Abnormal findings observed during an inspection
Acute Coronary Syndrome III: Diagnostic Studies
Clinical Applications of Epidermal Stem Cells
Myocarditis II: Clinical Features and Diagnostic Tests

